Meet Matt
Techy, super dad and gym rat— hear how Eversense helps Matt be engaged and focused, with no worries that his sensor will be knocked off, no matter what life throws at him.
Welcome to the Eversense community.
Here you can dive deeper into real stories from members of our community, as well as share your own.
Want to tell us your
story?
We’d love to hear it. Click the link below and answer a few simple questions on the form. We’ll get in contact with you if your story is chosen to be shared with the broader community.
Learn More
Calibration
Learn how to set up and calibrate your system to start getting your glucose data and the most accurate readings possible.
Traveling With Eversense E3 Is Easy And Convenient
When getting ready for traveling with diabetes, there is so much to think about, isn’t there? Of course, you need to be well prepared. With Eversense there is less hassle, and your packing list is pretty short.
Get Ready For Your Next E3 Sensor
Preparing for your next sensor in advance will ensure a smooth and uninterrupted experience.
Incision Care
Stay in the know with the Eversense E3 and get helpful pointers on how to manage your diabetes with it.
* There is no glucose data generated when the transmitter is removed
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0048